Somatostatin Acetate

Somatostatin, also known as growth hormone–inhibiting hormone (GHIH), is a peptide hormone that regulates the endocrine system and affects neurotransmission and cell proliferation via interaction with G protein-coupled somatostatin receptors and inhibition of the release of numerous secondary hormones. Somatostatin inhibits insulin and glucagon secretion. Somatostatin has two active forms produced by alternative cleavage of a single preproprotein: one of 14 amino acids (shown in infobox to right), the other of 28 amino acids which is the short form with another 14 amino acids at one end.

Related Prodcuts:

Icatibant; Lanreotide; Nesiritide; Leuprolide Acetate; Liraglutide; Lypressin; Atosiban; Oxytocin; Pasireotide; Bivalirudin; Pramlintide Acetate; Calcitonin Salmon; Alarelin Acetate; Sincalide; Glucagon HCl

1: Virgolini I, Gabriel M, Kroiss A, von Guggenberg E, Prommegger R, Warwitz B, Nilica B, Roig LG, Rodrigues M, Uprimny C. Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUV(max) reference range for management of pancreatic neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2016 May 13. [Epub ahead of print] Review. PubMed PMID: 27174220.

2: Tartarone A, Lerose R, Aieta M. Somatostatin Analog Therapy in Small Cell Lung Cancer. Semin Nucl Med. 2016 May;46(3):239-42. doi: 10.1053/j.semnuclmed.2015.12.004. Review. PubMed PMID: 27067504.